Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study TJ Wang, KC Wollert, MG Larson, E Coglianese, EL McCabe, S Cheng, ... Circulation 126 (13), 1596-1604, 2012 | 579 | 2012 |
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community RH Böger, LM Sullivan, E Schwedhelm, TJ Wang, R Maas, EJ Benjamin, ... Circulation 119 (12), 1592-1600, 2009 | 452 | 2009 |
Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study S Cheng, V Xanthakis, LM Sullivan, W Lieb, J Massaro, J Aragam, ... Circulation 122 (6), 570-578, 2010 | 318 | 2010 |
Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study V Xanthakis, DM Enserro, JM Murabito, JF Polak, KC Wollert, JL Januzzi, ... Circulation 130 (19), 1676-1683, 2014 | 252 | 2014 |
Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short-and long-term change in the framingham offspring study W Lieb, V Xanthakis, LM Sullivan, J Aragam, MJ Pencina, MG Larson, ... Circulation 119 (24), 3085-3092, 2009 | 224 | 2009 |
Epidemiology of left ventricular systolic dysfunction and heart failure in the Framingham study: an echocardiographic study over 3 decades RS Vasan, V Xanthakis, A Lyass, C Andersson, C Tsao, S Cheng, ... JACC: Cardiovascular Imaging 11 (1), 1-11, 2018 | 223 | 2018 |
Aortic root remodeling over the adult life course: longitudinal data from the Framingham Heart Study CSP Lam, V Xanthakis, LM Sullivan, W Lieb, J Aragam, MM Redfield, ... Circulation 122 (9), 884-890, 2010 | 205 | 2010 |
Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study S Cheng, V Xanthakis, LM Sullivan, RS Vasan Hypertension 60 (6), 1393-1399, 2012 | 203 | 2012 |
Trajectories of blood lipid concentrations over the adult life course and risk of cardiovascular disease and all‐cause mortality: observations from the Framingham study over 35 … MS Duncan, RS Vasan, V Xanthakis Journal of the American Heart Association 8 (11), e011433, 2019 | 150 | 2019 |
Association of ideal cardiovascular health with vascular brain injury and incident dementia MP Pase, A Beiser, D Enserro, V Xanthakis, H Aparicio, CL Satizabal, ... Stroke 47 (5), 1201-1206, 2016 | 145 | 2016 |
Ceramide remodeling and risk of cardiovascular events and mortality LR Peterson, V Xanthakis, MS Duncan, S Gross, N Friedrich, H Völzke, ... Journal of the American Heart Association 7 (10), e007931, 2018 | 136 | 2018 |
Longitudinal tracking of left atrial diameter over the adult life course: clinical correlates in the community DD McManus, V Xanthakis, LM Sullivan, J Zachariah, J Aragam, ... Circulation 121 (5), 667-674, 2010 | 128 | 2010 |
Prevalence, neurohormonal correlates, and prognosis of heart failure stages in the community V Xanthakis, DM Enserro, MG Larson, KC Wollert, JL Januzzi, D Levy, ... JACC: Heart Failure 4 (10), 808-815, 2016 | 127 | 2016 |
Interrelations between arterial stiffness, target organ damage, and cardiovascular disease outcomes RS Vasan, MI Short, TJ Niiranen, V Xanthakis, C DeCarli, S Cheng, ... Journal of the American Heart Association 8 (14), e012141, 2019 | 126 | 2019 |
Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community CSP Lam, MH Chen, SM Lacey, Q Yang, LM Sullivan, V Xanthakis, ... Arteriosclerosis, thrombosis, and vascular biology 30 (7), 1479-1484, 2010 | 114 | 2010 |
Identification of cis- and trans-Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels S Debette, S Visvikis-Siest, MH Chen, NC Ndiaye, C Song, A Destefano, ... Circulation research 109 (5), 554-563, 2011 | 103 | 2011 |
Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function W Lieb, R Safa, EJ Benjamin, V Xanthakis, X Yin, LM Sullivan, MG Larson, ... European heart journal 30 (9), 1121-1127, 2009 | 103 | 2009 |
Twenty‐year trends in the American Heart Association cardiovascular health score and impact on subclinical and clinical cardiovascular disease: the Framingham Offspring Study DM Enserro, RS Vasan, V Xanthakis Journal of the American Heart Association 7 (11), e008741, 2018 | 101 | 2018 |
Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all‐cause mortality in elderly men from the F ramingham H eart S tudy R Haring, Z Teng, V Xanthakis, A Coviello, L Sullivan, S Bhasin, ... Clinical endocrinology 78 (4), 629-634, 2013 | 100 | 2013 |
Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening V Xanthakis, MG Larson, KC Wollert, J Aragam, S Cheng, J Ho, ... Journal of the American Heart Association 2 (6), e000399, 2013 | 97 | 2013 |